Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study. (Q33385878)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study. |
scientific article |
Statements
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study (English)
Stefan Sleijfer
Constantijne H Mom
Corina N A M Oldenhuis
Norma Lynn Fox
Renée Miceli
Ferry A L M Eskens
Walter J Loos
18 August 2009